{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:39:50Z","timestamp":1789468790749,"version":"build-2803163510"},"reference-count":31,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2024.0070","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T09:56:27Z","timestamp":1720086987000},"source":"Crossref","is-referenced-by-count":7,"title":["Clinical practice guideline: Microhematuria in children and young adults\u2014evaluation for the early detection of kidney disease"],"prefix":"10.3238","author":[{"given":"Kay","family":"Latta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Boeckhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Weinreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Borisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"key":"10.3238\/arztebl.m2024.0070_ref1","doi-asserted-by":"crossref","unstructured":"Gross O, Licht C, Anders HJ, et al.: Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 2012; 81: 494–501.","DOI":"10.1038\/ki.2011.407"},{"key":"10.3238\/arztebl.m2024.0070_ref2","doi-asserted-by":"crossref","unstructured":"Gross O, Kashtan CE, Rheault MN, et al.: Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 Int. Workshop on Alport Syndrome. Nephrol Dial Transplant 2017; 32: 916–24.","DOI":"10.1093\/ndt\/gfw095"},{"key":"10.3238\/arztebl.m2024.0070_ref3","doi-asserted-by":"crossref","unstructured":"Kashtan CE, Gross O: Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults. Pediatr Nephrol 2021; 36: 711–9.","DOI":"10.1007\/s00467-020-04819-6"},{"key":"10.3238\/arztebl.m2024.0070_ref4","doi-asserted-by":"crossref","unstructured":"Kallash M, Rheault MN: Approach to persistent microscopic hematuria in children. Kidney360 2020; 1: 1014–20.","DOI":"10.34067\/KID.0003222020"},{"key":"10.3238\/arztebl.m2024.0070_ref5","doi-asserted-by":"crossref","unstructured":"Calderon-Margalit R, Golan E, Twig G, et al.: History of childhood kidney disease and risk of adult end-stage renal disease. N Engl J Med 2018; 378: 428–38.","DOI":"10.1056\/NEJMoa1700993"},{"key":"10.3238\/arztebl.m2024.0070_ref6","doi-asserted-by":"crossref","unstructured":"ESCAPE Trial Group; W\u00fchl E, Trivelli A, et al.: Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009; 361: 1639–50.","DOI":"10.1056\/NEJMoa0902066"},{"key":"10.3238\/arztebl.m2024.0070_ref7","doi-asserted-by":"crossref","unstructured":"K\u00f6hler H, Wandel E, Brunck B: Acanthocyturia—a characteristic marker for glomerular bleeding. Kidney Int 1991; 40: 115–20.","DOI":"10.1038\/ki.1991.188"},{"key":"10.3238\/arztebl.m2024.0070_ref8","doi-asserted-by":"crossref","unstructured":"Fogazzi GB, Edefonti A, Garigali G, et al.: Urine erythrocyte morphology in patients with microscopic haematuria caused by a glomerulopathy. Pediatr Nephrol 2008; 23: 1093–100.","DOI":"10.1007\/s00467-008-0777-2"},{"key":"10.3238\/arztebl.m2024.0070_ref9","unstructured":"F\u00fcnfst\u00fcck R, Stein G: [Erythrocytes in the urine: glomerulonephritis or other source of bleeding. Answer with the microscope]. MMW Fortschr Med 2000; 142: 30–2."},{"key":"10.3238\/arztebl.m2024.0070_ref10","doi-asserted-by":"crossref","unstructured":"Hicks J, Mierau G, Wartchow E, Eldin K: Renal diseases associated with hematuria in children and adolescents: a brief tutorial. Ultrastruct Pathol 2012; 36: 1–18.","DOI":"10.3109\/01913123.2011.620731"},{"key":"10.3238\/arztebl.m2024.0070_ref11","doi-asserted-by":"crossref","unstructured":"Meyers KEC: Evaluation of hematuria in children. Urol Clin North Am 2004; 31: 559–73.","DOI":"10.1016\/j.ucl.2004.04.015"},{"key":"10.3238\/arztebl.m2024.0070_ref12","doi-asserted-by":"crossref","unstructured":"Brown DD, Reidy KJ: Approach to the child with hematuria. Pediatr Clin North Am 2019; 66: 15–30.","DOI":"10.1016\/j.pcl.2018.08.003"},{"key":"10.3238\/arztebl.m2024.0070_ref13","doi-asserted-by":"crossref","unstructured":"van den Belt SM, Heerspink HJL, Gracchi V, et al.: Early proteinuria lowering by angiotensin-converting enzyme inhibition predicts renal survival in children with CKD. J Am Soc Nephrol 2018; 29: 2225–33.","DOI":"10.1681\/ASN.2018010036"},{"key":"10.3238\/arztebl.m2024.0070_ref14","unstructured":"Gross O, T\u00f6nshoff B, Weber LT, et al.: A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport‘s syndrome. Kidney Int 2020; 97: 1275–86."},{"key":"10.3238\/arztebl.m2024.0070_ref15","doi-asserted-by":"crossref","unstructured":"Boeckhaus J, Hoefele J, Riedhammer KM, et al.: Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study. Nephrol Dial Transplant 2022; 37: 2496–504.","DOI":"10.1093\/ndt\/gfac006"},{"key":"10.3238\/arztebl.m2024.0070_ref16","doi-asserted-by":"crossref","unstructured":"Seitz C, Bach T, Bader M, et al.: Aktualisierung der S2k-Leitlinie zur Diagnostik, Therapie und Metaphylaxe der Urolithiasis (AWMF Registernummer 043–025). Urologe 2019; 58: 1304–12.","DOI":"10.1007\/s00120-019-01033-7"},{"key":"10.3238\/arztebl.m2024.0070_ref17","doi-asserted-by":"crossref","unstructured":"Algoet C, Proesmans W: Renal biopsy 2–9 years after Henoch Sch\u00f6nlein purpura. Pediatr Nephrol 2003; 18: 471–3.","DOI":"10.1007\/s00467-003-1132-2"},{"key":"10.3238\/arztebl.m2024.0070_ref18","doi-asserted-by":"crossref","unstructured":"Hogg R: An evaluation of the roles of hematuria and uric acid in defining the prognosis of patients with IgA nephropathy. Pediatr Nephrol 2022; 37: 947–58.","DOI":"10.1007\/s00467-021-05092-x"},{"key":"10.3238\/arztebl.m2024.0070_ref19","doi-asserted-by":"crossref","unstructured":"Suh JS, Jang KM, Hyun H, et al.: Remission of proteinuria may protect against progression to chronic kidney disease in pediatric-onset IgA nephropathy. J Clin Med 2020; 9: 2058.","DOI":"10.3390\/jcm9072058"},{"key":"10.3238\/arztebl.m2024.0070_ref20","doi-asserted-by":"crossref","unstructured":"Alshami A, Roshan A, Catapang M, et al.: Indications for kidney biopsy in idiopathic childhood nephrotic syndrome. Pediatr Nephrol 2017; 32: 1897–1905.","DOI":"10.1007\/s00467-017-3687-3"},{"key":"10.3238\/arztebl.m2024.0070_ref21","doi-asserted-by":"crossref","unstructured":"Devasahayam J, Erode-Singa0ravelu G, Bhat Z, et al.: C1q nephropathy: the unique underrecognized pathological entity. Anal Cell Pathol (Amst) 2015; 2015: 490413.","DOI":"10.1155\/2015\/490413"},{"key":"10.3238\/arztebl.m2024.0070_ref22","unstructured":"Kashtan CE, Adam MP, Feldman J, et al.: Alport Syndrome. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993, 2001, [updated 2019 Feb 21]. PMID: 20301386."},{"key":"10.3238\/arztebl.m2024.0070_ref23","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs G, Kalm\u00e1r T, Endreffy E, et al.: Efficient targeted next generation sequencing-based workflow for differential diagnosis of alport-related disorders. PLoS One 2016; 11: e0149241.","DOI":"10.1371\/journal.pone.0149241"},{"key":"10.3238\/arztebl.m2024.0070_ref24","doi-asserted-by":"crossref","unstructured":"Goka S, Copelovitch L, Levy Erez D: Long-term outcome among females with Alport syndrome from a single pediatric center. Pediatr Nephrol 2021; 36: 945–51.","DOI":"10.1007\/s00467-020-04748-4"},{"key":"10.3238\/arztebl.m2024.0070_ref25","doi-asserted-by":"crossref","unstructured":"Zhang L, Sun BC, Zhao BG, Ma QS: An overview of the multi-pronged approach in the diagnosis of Alport syndrome for 22 children in Northeast China. BMC Nephrol 2020; 21: 294.","DOI":"10.1186\/s12882-020-01962-y"},{"key":"10.3238\/arztebl.m2024.0070_ref26","doi-asserted-by":"crossref","unstructured":"Tiebosch AT, Frederik PM, van Breda Vriesman PJ, et al.: Thin-basement-membrane nephropathy in adults with persistent hematuria. N Engl J Med 1989; 320: 14–8.","DOI":"10.1056\/NEJM198901053200103"},{"key":"10.3238\/arztebl.m2024.0070_ref27","doi-asserted-by":"crossref","unstructured":"Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M: Meta-analysis of genotype-phenotype correlation in x-linked alport syndrome: impact on clinical counselling. Nephrol Dial Transplant 2002; 17: 1218–27.","DOI":"10.1093\/ndt\/17.7.1218"},{"key":"10.3238\/arztebl.m2024.0070_ref28","doi-asserted-by":"crossref","unstructured":"Alge JL, Bekheirnia N, Willcockson AR, et al.: Variants in genes coding for collagen type IV α-chains are frequent causes of persistent, isolated hematuria during childhood. Pediatr Nephrol 2023; 38: 687–95.","DOI":"10.1007\/s00467-022-05627-w"},{"key":"10.3238\/arztebl.m2024.0070_ref29","doi-asserted-by":"crossref","unstructured":"Boeckhaus J, Strenzke N, Storz C, Gross O, on behalf of the Gpn Study Group, Early Pro-Tect Alport Investigators: Characterization of sensorineural hearing loss in children with alport syndrome. Life (Basel) 2020; 10: 360.","DOI":"10.3390\/life10120360"},{"key":"10.3238\/arztebl.m2024.0070_ref30","doi-asserted-by":"crossref","unstructured":"Pfau K, Gross O, Bemme S, et al.: [Ocular alterations in patients with Alport syndrome—an update]. Ophthalmologie 2023; 120: 645–51.","DOI":"10.1007\/s00347-022-01805-1"},{"key":"10.3238\/arztebl.m2024.0070_ref31","doi-asserted-by":"crossref","unstructured":"H\u00e4ckl D, Kossack N, Schoenfelder T: [Prevalence, costs of medical treatment and modalities of dialysis-dependent chronic renal failure in Germany: comparison of dialysis care of nursing home residents and in outpatient units]. Gesundheitswesen 2021; 83: 818–28.","DOI":"10.1055\/a-1330-7152"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T09:57:19Z","timestamp":1720087039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":31,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2024.0070","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]}}}